Overview of the interleukin-1 family of ligands and receptors.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Seminars in Immunology

• Publication date

  2013-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.smim.2013.10.001PMID 24275600
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist

  2012cited by this paper
• Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes

  2012cited by this paper
• IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G

  2012cited by this paper
• Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behçet's disease: an open-label pilot study

  2011cited by this paper
• Abstract A211: A phase I study of MABp1, a first-in-human, first-true human monoclonal antibody against the IL-1 in patients with advanced cancers.

  2011cited by this paper
• Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity

  2011cited by this paper
• The IL-1 family: regulators of immunity

  2010cited by this paper
• Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation

  2010cited by this paper
• Interleukin 37 is a fundamental inhibitor of innate immunity

  2010cited by this paper
• IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation

  2009cited by this paper
• The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines1

  2008cited by this paper
• The interleukin‐1 receptor/Toll‐like receptor superfamily: 10 years of progress

  2008cited by this paper
• Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

  2008cited by this paper
• Cutting Edge: IL-1 Controls the IL-23 Response Induced by Gliadin, the Etiologic Agent in Celiac Disease1

  2008cited by this paper
• IL‐1F5 mediates anti‐inflammatory activity in the brain through induction of IL‐4 following interaction with SIGIRR/TIR8

  2008cited by this paper
• Protective Effect of IL-18 on Kainate- and IL-1β-Induced Cerebellar Ataxia in Mice1

  2008cited by this paper
• IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells

  2007cited by this paper
• IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

  2007cited by this paper
• IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo

  2007cited by this paper
• Abnormal T cell activation caused by the imbalance of the IL-1/IL-1R antagonist system is responsible for the development of experimental autoimmune encephalomyelitis.

  2006cited by this paper
• A crucial role for interleukin (IL)-1 in the induction of IL-17–producing T cells that mediate autoimmune encephalomyelitis

  2006cited by this paper
• Adenovirus expressing interleukin-1 receptor antagonist alleviates allergic airway inflammation in a murine model of asthma

  2006cited by this paper
• IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

  2005cited by this paper
• Prevention of IL-1 signaling attenuates airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma.

  2005cited by this paper
• The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.

  2004cited by this paper
• IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist

  2003cited by this paper
• Cytokine traps: multi-component, high-affinity blockers of cytokine action

  2003cited by this paper
• Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production.

  2002cited by this paper
• IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions

  2002cited by this paper
• Interleukin‐1β, but not interleukin‐1α, is required for T‐cell‐dependent antibody production

  2001cited by this paper
• Interleukin-1 beta, but not interleukin-1 alpha, is required for T-cell-dependent antibody production.

  2001cited by this paper
• Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu.

  2001cited by this paper
• Cutting Edge: IL-18-Transgenic Mice: In Vivo Evidence of a Broad Role for IL-18 in Modulating Immune Function

  2001cited by this paper
• The Human Toll Signaling Pathway: Divergence of Nuclear Factor κB and JNK/SAPK Activation Upstream of Tumor Necrosis Factor Receptor–associated Factor 6 (TRAF6)

  1998cited by this paper
• The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein.

  1997cited by this paper
• The N-terminal propiece of interleukin 1α is a transforming nuclear oncoprotein

  1997cited by this paper
• A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes

  1992cited by this paper
• Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the Drosophila toll protein are essential for IL-1R signal transduction.

  1992cited by this paper
• Drosophila Toll and IL-1 receptor

  1991cited by this paper
• Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

  1984cited by this paper
• Cloning and expression of murine interleukin-1 cDNA in Escherichia coli

  1984cited by this paper
• The role of interleukin 1 in human B cell activation: inhibition of B cell proliferation and the generation of immunoglobulin-secreting cells by an antibody against human leukocytic pyrogen.

  1983cited by this paper
• Studies of endotoxin-induced decrease in lipoprotein lipase activity

  1981cited by this paper
• Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media.

  1980cited by this paper
• Adherent cell function in murine T-lymphocyte antigen recognition. IV. Enhancement of murine T-cell antigen recognition by human leukocytic pyrogen

  1979cited by this paper
• Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.

  1978cited by this paper
• Human leukocytic pyrogen: purification and development of a radioimmunoassay.

  1977cited by this paper
• DEMONSTRATION AND CHARACTERIZATION OF TWO DISTINCT HUMAN LEUKOCYTIC PYROGENS

  1974cited by this paper
• Multiple biological activities of a partially purified leukocytic endogenous mediator.

  1973cited by this paper
• POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS

  1972cited by this paper

• Inflammatory Mediators in Peri-Implantitis: From Pathophysiology to Therapeutic Targets.

  2026cites this paper
• The Crosstalk Between Protective and Detrimental Interleukin (IL)‐1 Family of Cytokines in Alzheimer's Disease

  2025cites this paper
• A comprehensive review of dental bone regeneration

  2025cites this paper
• Uterine inflammation and lessons from large animal models of endometritis

  2025cites this paper
• Inflammatory cytokines and specific factors influencing lung cancer progression

  2025cites this paper
• Co-infection by RGNNV and V. rotiferianus in golden pompano: Insights into disease risks and immune responses

  2025cites this paper
• Nucleic acid aptamers in orthopedic diseases: promising therapeutic agents for bone disorders

  2025cites this paper
• Radiotherapy is enhanced by CPH:SA IL-1α microparticles in a murine HNSCC tumor model

  2025influential citation
• The Dual Role of Interferon Signaling in Myeloproliferative Neoplasms: Pathogenesis and Targeted Therapeutics

  2025cites this paper
• Early Postpartum IL-10 and IL-37 Concentrations in Women with Gestational Diabetes Mellitus

  2025cites this paper
• The role of inflammatory mediators and matrix metalloproteinases (MMPs) in the progression of osteoarthritis

  2024cites this paper
• The role of IL-1 family of cytokines in the pathogenesis and therapy of Alzheimer’s disease

  2024cites this paper
• Generalized Pustular Psoriasis, Acute Generalized Exanthematous Pustulosis, and Other Pustular Reactions: A Clinical Review.

  2024cites this paper
• Single Center-Based Real-World Experience on Anti-IL 1 Biological Response Modifiers: A Case Series and Literature Review

  2024cites this paper
• Targeting the NLRP3 inflammasome–IL-1β pathway in type 2 diabetes and obesity

  2024cites this paper
• Interleukins: Role in cancer and its immunotherapy

  2024cites this paper
• The Potential of Glucosinolates and Their Hydrolysis Products as Inhibitors of Cytokine Storms

  2024cites this paper
• Construction of a Multicellular Communication Network Model for Cell Co-Culture Technology and Evaluation of Its Simulation Capability

  2024cites this paper
• Pro-Inflammatory Cytokines and Post-Stroke Depression: Discussion and Thought

  2024cites this paper
• Molecular mechanisms of regulation of IL-1 and its receptors.

  2024cites this paper
• Titanium dioxide nanotubes applied to conventional glass ionomer cement influence the expression of immunoinflammatory markers: An in vitro study

  2024cites this paper
• Antibodies targeting the shared cytokine receptor IL-1 receptor accessory protein invoke distinct mechanisms to block all cytokine signaling

  2024cites this paper
• Cytokine balance in pregnant women with preeclampsia

  2024cites this paper
• Based on network pharmacology and molecular docking to explore the molecular mechanism of Ginseng and Astragalus decoction against postmenopausal osteoporosis

  2023cites this paper
• ASIC1a-CMPK2-mediated M1 macrophage polarization exacerbates chondrocyte senescence in osteoarthritis through IL-18.

  2023cites this paper
• Berberine attenuates uric acid-induced cell injury by inhibiting NLRP3 signaling pathway in HK-2 cells

  2023cites this paper
• Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors.

  2023cites this paper
• Interplay between IL-1α and TGF-β1 in the normal and hypertrophic wound healing

  2023cites this paper
• S100A8 and S100A9 are associated with endometrial shedding during menstruation

  2023cites this paper
• Potential therapeutic strategies for osteoarthritis via CRISPR/Cas9 mediated gene editing

  2023cites this paper
• Investigating the Potential Mechanisms and Therapeutic Targets of Inflammatory Cytokines in Post-stroke Depression

  2023cites this paper
• Role of Apoptosis in the Pathogenesis of Osteoarthriti1s: An explicative review.

  2023cites this paper
• Activation of IL1 signaling molecules by Kaposi’s sarcoma-associated herpesvirus

  2022cites this paper
• Development and characterization of a skin cell line from Chinese perch (Siniperca chuatsi) and its application in aquatic animal viruses.

  2022cites this paper
• Interleukin-33 and Soluble ST2 as Potential Biomarkers of Cancer in Opium Users: A Nested Case-Control Study

  2022cites this paper
• T cell-extrinsic IL-1 signaling controls long-term gammaherpesvirus infection by suppressing viral reactivation.

  2022cites this paper
• Do urinary metals associate with the homeostasis of inflammatory mediators? Results from the perspective of inflammatory signaling in middle-aged and older adults.

  2022cites this paper
• The Role of Anti-IL-1 Medications in Autoinflammatory Disease.

  2022cites this paper
• Characterization of CPH:SA microparticle‐based delivery of interleukin‐1 alpha for cancer immunotherapy

  2022cites this paper
• A systems biology analysis of protein-protein interaction of digestive disorders and Covid-19 virus based on comprehensive gene information

  2022cites this paper
• Effect of NLRP3 repression on NLRP3 inflammasome activation in human corneal epithelial cells with black carbon exposure

  2022cites this paper
• Cytokines in Thyroid-Associated Ophthalmopathy

  2022cites this paper
• Detection of IL-1β, VEGF and IL-4 with Their Novel Genetic Variations in Breast Cancer Patients

  2022cites this paper
• Cartilage tissue engineering: From proinflammatory and anti-inflammatory cytokines to osteoarthritis treatments

  2022cites this paper
• The IL-1 Family and Its Role in Atherosclerosis

  2022cites this paper
• NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: From cryopyrin function to targeted therapies

  2022cites this paper
• Central and Peripheral Immune Dysregulation in Posttraumatic Stress Disorder: Convergent Multi-Omics Evidence

  2022cites this paper
• Pathomechanisms of bone loss in rheumatoid arthritis

  2022cites this paper
• Evolution of developmental and comparative immunology in poultry: The regulators and the regulated.

  2022cites this paper
• Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders

  2022cites this paper
• Human and Bacterial Toll-Interleukin Receptor Domains Exhibit Distinct Dynamic Features and Functions

  2022cites this paper
• Detection of IL-1β, VEGF and IL-4 with their novel genetic variations in breast cancer patients

  2022cites this paper
• Colchicine for COVID-19: targeting NLRP3 inflammasome to blunt hyperinflammation

  2022cites this paper
• Comparison of Interleukin-1 Ligand Expression by Human Papilloma Virus Status in HNSCCs

  2022influential citation
• Hepatic interleukin‐1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver disease

  2022cites this paper
• Pyroptosis in Osteoblasts: A Novel Hypothesis Underlying the Pathogenesis of Osteoporosis

  2021influential citation
• The Roles of Inflammasomes in Host Defense against Mycobacterium tuberculosis

  2021cites this paper
• Association between Interleukin-1β Polymorphism at Rs16944 and Glucose Metabolism: A Cohort Study

  2021cites this paper
• The regulation of FGF23 production in bone and outside of bone

  2021cites this paper
• Mast Cell Cytokines IL-1, IL-33, and IL-36 Mediate Skin Inflammation in Psoriasis: A Novel Therapeutic Approach with the Anti-Inflammatory Cytokines IL-37, IL-38, and IL-1Ra

  2021influential citation
• Interleukins in adipose tissue: Keeping the balance.

  2021cites this paper
• Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers

  2021cites this paper
• Features of the immunological profile of blood and urine in patients with post-infectious glomerulonephritis.

  2021cites this paper
• Immunobiological Properties and Clinical Applications of Interleukin-38 for Immune-Mediated Disorders: A Systematic Review Study

  2021influential citation
• Mast Cells Mediate Skin Inflammation in Psoriasis: A New Therapeutic Approach with the Anti- inflammatory Cytokines IL-37, IL-38 or IL-1Ra INTRODUCTION Approximately 3% of the population of the United States of America and 2% of the whole world

  2021influential citation
• P2X7R antagonists in chronic stress-based depression models: a review

  2021cites this paper
• MMP9 mRNA is a potential diagnostic and treatment monitoring marker for PTSD: Evidence from mice and humans.

  2021cites this paper
• Clinical Applications of Interleukin-37: A Key Player in the Immunopathogenesis of Immune Disorders.

  2020cites this paper
• Pathophysiological landscape of osteoarthritis.

  2020cites this paper
• Downregulation of Inflammatory Cytokine Release from IL-1β and LPS-Stimulated PBMC Orchestrated by ST2825, a MyD88 Dimerisation Inhibitor

  2020cites this paper
• Antibiotics, Inflammation, and Preterm Labor: A Missed Conclusion

  2020cites this paper
• Role of Interleukin-1 Family Members and Signaling Pathways in KSHV Pathogenesis

  2020influential citation
• Role of the Inflammasome in Cancer

  2020cites this paper
• New aspect of allergic contact dermatitis, an inflammatory skin disorder mediated by mast cells: Can IL-38 help?

  2020cites this paper
• Rapamycin protects chondrocytes against IL-18-induced apoptosis and ameliorates rat osteoarthritis

  2020cites this paper
• Functional Characteristics of the Mouse Il1b Promoter in Various Tissues Before and After Irradiation

  2020cites this paper
• TRPM7 kinase-mediated immunomodulation in macrophage plays a central role in magnesium ion-induced bone regeneration

  2020cites this paper
• Comparative Analyses of the Conformational Dynamics Between the Soluble and Membrane-Bound Cytokine Receptors

  2020cites this paper
• Bacteria-induced IL-1β and its receptors in snakehead (Channa argus): Evidence for their involvement in antibacterial innate immunity.

  2020cites this paper
• Association between IL1B polymorphisms and the risk of rheumatoid arthritis.

  2020cites this paper
• Soluble mediators in packed red blood cells augment lipopolysaccharide‐induced monocyte interleukin‐1β production

  2020cites this paper
• The NLRP3 inflammasome in acute myocardial infarction.

  2019cites this paper
• Follicular structures of cows with cystic ovarian disease present altered expression of cytokines

  2019influential citation
• CAPS and NLRP3

  2019cites this paper
• Activation of mast cells mediates inflammatory response in psoriasis: Potential new therapeutic approach with IL‐37

  2019influential citation
• IL-36 Cytokines: Regulators of Inflammatory Responses and Their Emerging Role in Immunology of Reproduction

  2019influential citation
• One hits (almost) all

  2019cites this paper
• Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma

  2019cites this paper
• Impact of Nuclear Interleukin-1 Alpha and EGFR Expression on Recurrence and Survival Outcomes in Oral Squamous Cell Carcinomas

  2019influential citation
• RESPONSE OF LYMPHOID CELLS TO REGULATORY SIGNAL OF INTERLEUKIN 1 AS AN INDEX OF LYMPHOCYTE ACTIVITY

  2019cites this paper
• A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab

  2019cites this paper
• Cirsium japonicum var. maackii and apigenin block Hif‐2α‐induced osteoarthritic cartilage destruction

  2019cites this paper
• Genetic polymorphisms of ACE I/D, IL-1β G > A and IL-4 VNTR among Egyptian subjects with rheumatoid arthritis

  2019cites this paper
• Effects of different alcohol concentrations on the development of apical periodontitis in rats.

  2019cites this paper
• How to deal: Exploring the impact of coping, perceived control, and stress on immune function in patients with advanced cancer

  2019cites this paper
• Impact of neonatal malnutrition on expression TLR-9, NF-kB and cytokines of macrophages infected in vitro with methicillin resistant Staphylococcus aureus.

  2019cites this paper
• Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease

  2019cites this paper
• The Roles of IL-1 Family Cytokines in the Pathogenesis of Systemic Sclerosis

  2019cites this paper
• Expressions of TLR4, MyD88, IRAK4 and NF-ÎB in the oviduct of Chinese brown frog (Rana dybowskii)

  2019cites this paper
• Inflammation in the pathophysiology and therapy of cardiometabolic disease.

  2019cites this paper